Cannell & Spears’s QuidelOrtho QDEL Stock Holding History

Cannell & Spears’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,194	Closed	-$556K	–	418
2024 Q3	$556K	Buy	+12,194	New	+$493K	0.01%	289
2023 Q4	–	Sell	-5,647	Closed	-$412K	–	222
2023 Q3	$412K	Sell	5,647 -30,366	-84%	-$2.43M	0.04%	145
2023 Q2	$2.98M	Buy	+36,013	New	+$3.15M	0.24%	48

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cannell & Spears's QDEL Position: Q4 2024 in Review

Cannell & Spears sold out of QuidelOrtho (QDEL) in Q4 2024, closing a stake of 12,194 shares — an estimated $556K sold.

Cannell & Spears first reported a position in QDEL in Q2 2023 and held it in 3 quarters. The position peaked at $2.98M in Q2 2023. 275 funds tracked by Wall St. Rank hold QDEL as of Q4 2024.

Cannell & Spears reported no remaining QuidelOrtho position as of Q4 2024 after selling out during the quarter.
Cannell & Spears sold 12,194 QuidelOrtho shares in Q4 2024, an estimated $556K.
Cannell & Spears first reported a position in QuidelOrtho in Q2 2023 and held it in 3 quarters.
Cannell & Spears's QuidelOrtho position peaked at $2.98M in Q2 2023.
275 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2024.

Based on Cannell & Spears's 13F filing for Q4 2024, filed 12 Feb 2025.